X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (863) 863
Publication (183) 183
Data Set (7) 7
Book Chapter (4) 4
Book Review (3) 3
Conference Proceeding (2) 2
Newspaper Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (499) 499
female (442) 442
adult (334) 334
infectious diseases (324) 324
male (314) 314
index medicus (303) 303
hiv (294) 294
hiv infections - drug therapy (231) 231
immunology (228) 228
middle aged (184) 184
antiretroviral therapy (173) 173
cohort studies (158) 158
hiv infection (157) 157
human immunodeficiency virus--hiv (149) 149
aids (148) 148
mortality (145) 145
risk factors (145) 145
life sciences (140) 140
cd4 lymphocyte count (138) 138
africa (130) 130
pregnancy (127) 127
virology (126) 126
anti-hiv agents - therapeutic use (123) 123
hiv-1 (113) 113
santé publique et épidémiologie (109) 109
hiv infections - epidemiology (104) 104
viral load (102) 102
adolescent (99) 99
drug therapy (95) 95
hiv infections - complications (95) 95
aids/hiv (94) 94
antiviral agents (93) 93
hiv infections - transmission (93) 93
health aspects (90) 90
research (90) 90
prevention (89) 89
[ sdv.spee ] life sciences [q-bio]/santé publique et épidémiologie (87) 87
hiv infections (83) 83
antiretroviral drugs (82) 82
infant (81) 81
infant, newborn (81) 81
human-immunodeficiency-virus (77) 77
article (76) 76
highly active antiretroviral therapy (75) 75
hiv infections - immunology (75) 75
[sdv.spee]life sciences [q-bio]/santé publique et épidémiologie (73) 73
acquired immune deficiency syndrome--aids (73) 73
hiv infections - virology (73) 73
hiv infections - mortality (71) 71
epidemiology (70) 70
antiretroviral therapy, highly active (69) 69
cote d'ivoire (69) 69
prospective studies (69) 69
virus diseases (69) 69
research article (68) 68
young adult (68) 68
human immunodeficiency virus (66) 66
public, environmental & occupational health (66) 66
treatment outcome (66) 66
infectious disease transmission, vertical - prevention & control (65) 65
hiv infections - prevention & control (64) 64
infection (62) 62
microbiology (62) 62
risk (62) 62
time factors (62) 62
infections (61) 61
anti-retroviral agents - therapeutic use (60) 60
disease transmission (60) 60
prevalence (59) 59
disease progression (58) 58
medicine, general & internal (57) 57
women (57) 57
cohort (56) 56
therapy (55) 55
cote-divoire (54) 54
mesh : humans (54) 54
care and treatment (53) 53
analysis (52) 52
hiv infections - diagnosis (50) 50
hiv patients (50) 50
antiretroviral agents (49) 49
child (47) 47
incidence (47) 47
mesh : female (47) 47
adults (46) 46
medicine (46) 46
mesh : hiv infections (46) 46
aged (45) 45
sub-saharan africa (45) 45
acquired immune deficiency syndrome (44) 44
cross-sectional studies (44) 44
follow-up studies (44) 44
transmission (44) 44
child, preschool (43) 43
developing countries (43) 43
infected patients (42) 42
children (41) 41
hiv/aids (41) 41
zidovudine (41) 41
breast feeding (40) 40
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
PLoS Medicine, ISSN 1549-1277, 08/2016, Volume 13, Issue 8, p. e1002107
Journal Article
BMC Infectious Diseases, ISSN 1471-2334, 10/2010, Volume 10, Issue 1, pp. 303 - 303
Background: In France, it is estimated that 24% of HIV-infected patients are also infected with HCV. Longitudinal studies addressing clinical and public health... 
TRANSIENT ELASTOGRAPHY | DRUG-USERS | INFECTIOUS DISEASES | REAL-LIFE | CHRONIC HEPATITIS-C | ACTIVE ANTIRETROVIRAL THERAPY | LIVER FIBROSIS | ALPHA-2A PLUS RIBAVIRIN | HUMAN-IMMUNODEFICIENCY-VIRUS | CLINICAL PROGRESSION | MORTALITE 2005 | Carcinoma, Hepatocellular - epidemiology | Hepatitis C, Chronic - pathology | HIV Infections - epidemiology | Humans | Middle Aged | Male | RNA, Viral - blood | Hepatitis C, Chronic - complications | Viral Load | Liver Neoplasms - epidemiology | HIV Infections - pathology | HIV-1 - isolation & purification | Adult | Anti-HIV Agents - therapeutic use | Female | Surveys and Questionnaires | Hepatitis C, Chronic - epidemiology | Hepacivirus - isolation & purification | France - epidemiology | Risk Factors | CD4 Lymphocyte Count | Hepatitis C, Chronic - drug therapy | Disease Progression | Antiretroviral Therapy, Highly Active | Medication Adherence | HIV Infections - complications | HIV Infections - drug therapy | Longitudinal Studies | Cohort analysis | Usage | Demographic aspects | Comorbidity | Distribution | Reports | Hepatitis C | HIV infection | Antiretroviral drugs | Liver diseases | Disease | Physicians | Mortality | Hepatitis | Liver cancer | Hospitals | Human immunodeficiency virus--HIV | Data collection | Behavior | Clinical medicine | Liver cirrhosis | Life Sciences | Human health and pathology | Infectious diseases
Journal Article
Journal Article
Hepatology, ISSN 0270-9139, 11/2016, Volume 64, Issue 5, pp. 1462 - 1472
Journal Article
PLoS Medicine, ISSN 1549-1277, 2007, Volume 4, Issue 8, pp. 1362 - 1373
Background Highly active antiretroviral treatment ( HAART) has only been recently recommended for HIV-infected pregnant women requiring treatment for their own... 
SINGLE-DOSE NEVIRAPINE | MEDICINE, GENERAL & INTERNAL | MOTHER-TO-CHILD | LOW-BIRTH-WEIGHT | COTE-DIVOIRE | IMMUNODEFICIENCY-VIRUS TYPE-1 | BREAST-FED CHILDREN | RANDOMIZED-TRIAL | PREGNANT-WOMEN | VERTICAL TRANSMISSION | ORAL ZIDOVUDINE | HIV-1 | HIV Infections - prevention & control | Lamivudine - administration & dosage | Follow-Up Studies | Humans | Antiretroviral Therapy, Highly Active - adverse effects | Infant | Male | Nevirapine - therapeutic use | Cote d'Ivoire - epidemiology | Viral Load | Zidovudine - administration & dosage | Anti-HIV Agents - administration & dosage | Antiretroviral Therapy, Highly Active - utilization | Lamivudine - therapeutic use | Anti-HIV Agents - therapeutic use | Female | HIV Infections - transmission | Infant, Newborn | Infant, Low Birth Weight | Anti-HIV Agents - adverse effects | HIV Infections - congenital | CD4 Lymphocyte Count | Pregnancy | Puerperal Disorders - drug therapy | Breast Feeding - adverse effects | Pregnancy Complications, Infectious - drug therapy | HIV Infections - drug therapy | Zidovudine - therapeutic use | Program Evaluation | Nevirapine - administration & dosage | Infectious Disease Transmission, Vertical - prevention & control | Cohort Studies | Prevention | Antiviral agents | Disease transmission | Pregnant women | Dosage and administration | HIV infection in children | Drug therapy | HIV infection | Health aspects | Methods | Life Sciences | Santé publique et épidémiologie | Public Health and Epidemiology | Medicine in Developing Countries | Cohort studies | Infectious Diseases | AIDS | Infants | HIV Infection | HIV | Acquired immune deficiency syndrome | Womens health | Human immunodeficiency virus
Journal Article
Lancet, The, ISSN 0140-6736, 2016, Volume 387, Issue 10034, pp. 2196 - 2197
Journal Article
Journal Article